Liver Neoplasm Clinical Trial
Official title:
Feasibility of Ultrasound-based Navigation for Non-anatomical Liver Resections
NCT number | NCT04187937 |
Other study ID # | USGR |
Secondary ID | |
Status | Terminated |
Phase | N/A |
First received | |
Last updated | |
Start date | June 17, 2020 |
Est. completion date | February 16, 2022 |
Verified date | May 2022 |
Source | University Hospital Inselspital, Berne |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In a non-anatomical resection of a liver tumor, only the part of the liver with the tumor and a safety margin of 5 - 10 mm are resected. This is done to ensure a negative resection margin, which means that no tumor cells are at the boundary of the resection. These non-anatomical resections can be performed repeatedly in case of recurrence. However, compared to anatomical resections, it is more challenging to keep a negative resection margin as anatomical landmarks cannot be used for intra-operative guidance. In this study, the investigators aim to clinically evaluate a 3d navigation system, where navigated intra-operative ultrasound data is used to create a virtual model and a surgical plan.
Status | Terminated |
Enrollment | 1 |
Est. completion date | February 16, 2022 |
Est. primary completion date | February 16, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients which are regularly scheduled for an open surgical liver resection - At least one tumor considered for non-anatomical resection - Lesion is visible on ultrasound imaging - Informed Consent as documented by signature (Appendix Informed Consent Form) - Age >= 18 years Exclusion Criteria: - Other clinically condition or disease that would (as deemed by the operating surgeon) significantly increase the risk of surgery - Lesion is close to major vessel (< 10 mm) - Lesion is too large to be visualized on ultrasound imaging - Emergency - Subjects not able to give informed consent (dementia) - Women of childbearing potential (less than 1 year post-menopausal) |
Country | Name | City | State |
---|---|---|---|
Switzerland | Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern | Bern |
Lead Sponsor | Collaborator |
---|---|
University Hospital Inselspital, Berne | University of Bern |
Switzerland,
Banz VM, Müller PC, Tinguely P, Inderbitzin D, Ribes D, Peterhans M, Candinas D, Weber S. Intraoperative image-guided navigation system: development and applicability in 65 patients undergoing liver surgery. Langenbecks Arch Surg. 2016 Jun;401(4):495-502. doi: 10.1007/s00423-016-1417-0. Epub 2016 Apr 28. — View Citation
Kingham TP, Jayaraman S, Clements LW, Scherer MA, Stefansic JD, Jarnagin WR. Evolution of image-guided liver surgery: transition from open to laparoscopic procedures. J Gastrointest Surg. 2013 Jul;17(7):1274-82. doi: 10.1007/s11605-013-2214-5. Epub 2013 May 4. — View Citation
Langø T, Vijayan S, Rethy A, Våpenstad C, Solberg OV, Mårvik R, Johnsen G, Hernes TN. Navigated laparoscopic ultrasound in abdominal soft tissue surgery: technological overview and perspectives. Int J Comput Assist Radiol Surg. 2012 Jul;7(4):585-99. doi: 10.1007/s11548-011-0656-3. Epub 2011 Sep 3. Review. — View Citation
Moris D, Tsilimigras DI, Kostakis ID, Ntanasis-Stathopoulos I, Shah KN, Felekouras E, Pawlik TM. Anatomic versus non-anatomic resection for hepatocellular carcinoma: A systematic review and meta-analysis. Eur J Surg Oncol. 2018 Jul;44(7):927-938. doi: 10.1016/j.ejso.2018.04.018. Epub 2018 Apr 30. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | R0 resection rate | Assessed by histopathological examination of the resected specimen. R0 is defined as a negative resection margin of >1 mm. | 30 days | |
Secondary | Number of re-resections | intra-operative, expected to be up to 4 hours | ||
Secondary | Resection margin in mm | 30 days | ||
Secondary | Correlation with tumor size | pre-operative, expected to be up to 30 days | ||
Secondary | Correlation with tumor volume | pre-operative, expected to be up to 30 days | ||
Secondary | Correlation with tumor type | pre-operative, expected to be up to 30 days | ||
Secondary | Correlation with tumor location | pre-operative, expected to be up to 30 days | ||
Secondary | Time for planning of the resection | intra-operative, expected to be up to 4 hours | ||
Secondary | Time for resection | intra-operative, expected to be up to 4 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02557724 -
Mobilization of Mesenchymal Stem Cells During Liver Transplantation
|
||
Terminated |
NCT04702230 -
Value of Functional Magnetic Resonance Imaging of Hepatocellular Carcinoma After Transarterial Chemoembolization or Transarterial Radioembolization
|
||
Active, not recruiting |
NCT01217034 -
Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib
|
Phase 2 | |
Recruiting |
NCT05169177 -
Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy
|
||
Withdrawn |
NCT02599909 -
Gut Microbiota in People With Hepatocellular Carcinoma (HCC)
|
||
Terminated |
NCT03998033 -
Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma
|
Phase 1 | |
Recruiting |
NCT04010071 -
Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors
|
Phase 2 | |
Recruiting |
NCT04864054 -
T-Cell Therapy (ECT204) in Adults With Advanced HCC
|
Phase 2 | |
Completed |
NCT02471313 -
Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization
|
Phase 2 | |
Completed |
NCT00001576 -
A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver
|
Phase 1 | |
Recruiting |
NCT01542281 -
Pre-habilitation to Improve Outcomes in Patients Undergoing Liver Resection for Cancer
|
N/A | |
Recruiting |
NCT03803436 -
Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation
|
Phase 2 | |
Completed |
NCT05495529 -
Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors
|
||
Recruiting |
NCT02632864 -
Feasibility of High Dose PROton Therapy On Unresectable Primary Carcinoma Of Liver: Prospective Phase II Trial
|
Phase 2 | |
Completed |
NCT02571946 -
Proton Beam Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis
|
N/A | |
Not yet recruiting |
NCT01180088 -
Effectiveness of Routine Application Of Anterior Approach During Right Hepatectomy
|
N/A | |
Withdrawn |
NCT00510627 -
Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases
|
Phase 4 | |
Completed |
NCT05848947 -
SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA
|
Phase 4 | |
Not yet recruiting |
NCT05723705 -
Impact of a European Training Program for Robotic Liver Surgery (LIVEROBOT)
|
||
Terminated |
NCT04502082 -
Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)
|
Phase 1/Phase 2 |